Analyst Ratings News 17 December 2025

Establishment Labs (ESTA) Stock Drops on Dec. 18, 2025 After a Fresh 52-Week High as Analysts Lift Price Targets

Establishment Labs Holdings Inc. (NASDAQ: ESTA) has become one of the more closely watched mid-cap medtech stories of late 2025—surging to new highs this week, then snapping back sharply on Thursday, December 18. Shares of Establishment Labs ended the day

18 December 2025

Analyst Ratings·Company Updates·Financial News·Investing·Stock Market

Procter & Gamble (PG) Stock Today: JPMorgan Cuts Price Target to $157 as Wall Street Weighs 2026 Catalysts

December 18, 2025 — Procter & Gamble (NYSE: PG) shares traded lower on Thursday as investors digested fresh sell-side research updates and recalibrated expectations for 2026. PG was last seen around $145.5, down roughly 1.6% on the session, after closing

18 December 2025

Analyst Ratings·Company News·Financial Analysis·Investing·Stock Market

Wave Life Sciences (WVE) Stock News Today (Dec. 18, 2025): Why Shares Are Sliding, New Analyst Targets, and the Next Catalysts After WVE-007 Obesity Data

Wave Life Sciences Ltd. (NASDAQ: WVE) is back in the spotlight on December 18, 2025—not because of a brand-new press release, but because the stock is still digesting one of the most volatile biotech weeks of the year. In Thursday

18 December 2025

Analyst Ratings·Biotech Stocks·Investment Insights·Stock Market News

ABM Industries (NYSE:ABM) Stock Slides on Dec. 18 After Q4 Earnings: WGNSTAR Deal, 2026 Outlook, Dividend Hike and Analyst Calls

ABM Industries Incorporated (NYSE: ABM) stock was sharply lower in Thursday trading (December 18, 2025), with shares recently changing hands near $43.13, down about 10.6% from the prior close after a volatile session that saw the stock trade between $43.02

18 December 2025

Analyst Ratings·Dividend News·Earnings Reports·Mergers & Acquisitions·Stock Market

Ondas Holdings (ONDS) Stock Today (Dec. 18, 2025): Shares Rally on Demining Pilot Results, New COO, and Fresh Analyst Targets

Ondas Holdings Inc. (NASDAQ: ONDS) is back in the market’s spotlight on Thursday, December 18, 2025, with the stock trading around the $8 level and showing sharp intraday gains on unusually heavy volume—a reminder that ONDS is currently priced like

18 December 2025

Analyst Ratings·Company Updates·Stock Market News

Applied Materials (AMAT) Stock News Today: Analyst Price Targets Shift Higher as AI Chip Equipment Forecasts Strengthen (Dec. 18, 2025)

Applied Materials, Inc. (NASDAQ: AMAT) is back in focus on December 18, 2025, as the semiconductor equipment leader trades higher after a volatile week for chip-related names. A fresh price-target hike from B. Riley, an updated Mizuho target, and a

18 December 2025

AI Technology·Analyst Ratings·Investment Insights·Semiconductor Industry·Stock Market News

Micron Technology Stock (MU) Surges on Blowout Guidance: AI HBM Demand, Supply Crunch, and New Analyst Targets (Dec. 18, 2025)

Micron Technology, Inc. (NASDAQ: MU) stock jumped sharply on Thursday, Dec. 18, after the memory-chip maker delivered a blockbuster quarter and issued a far-stronger-than-expected outlook—reigniting the “AI infrastructure” trade across semiconductors and putting Micron’s high-bandwidth memory (HBM) strategy at center

18 December 2025

AI·Analyst Ratings·Investment·Stock Market·Technology

Recursion Pharmaceuticals (RXRX) Stock News & Forecast (Dec. 18, 2025): JPMorgan Upgrade, REC-4881 Trial Momentum, and What Analysts See Next

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is back in the market’s spotlight on December 18, 2025, after a sharp move higher driven by fresh Wall Street optimism and a growing pile of real-world “proof points” for the company’s AI-driven drug discovery

18 December 2025

Analyst Ratings·Clinical Trials·Investment Analysis·Pharmaceuticals·Stock Market

Iovance Biotherapeutics (IOVA) Stock News Today (Dec. 18, 2025): Barclays Lifts Target to $10, Analysts Stay Split on Amtagvi’s Launch

December 18, 2025 — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is back in the spotlight after a sharp two-day move that pushed the stock back to the $2.5 area—still far below where many Wall Street price targets sit, but enough to

18 December 2025

Analyst Ratings·Biotech Stocks·Investment Updates·Pharma Industry·Stock Market News

Boston Scientific (BSX) Stock After Hours on Dec. 17, 2025: Analysts Stay Bullish as Shares Close Higher — What to Watch Before Thursday’s Open

Boston Scientific Corporation (NYSE: BSX) ended Wednesday, December 17, 2025, in positive territory even as the broader market sold off. The medical-device maker’s shares closed up 1.65% at $94.48, extending gains for a second session and outperforming several large medtech

18 December 2025

After Hours Trading·Analyst Ratings·Financial News·Investing·Stock Market

Bank of America Stock (BAC) After Hours Today (Dec. 17, 2025): Price Action, Fresh Analyst Targets, Activist Buzz, and What to Watch Before Thursday’s Open

Bank of America Corporation (NYSE: BAC) ended Wednesday, December 17, 2025, under mild pressure during regular trading — and then stayed mostly steady after the closing bell as investors digested a mix of market-wide risk-off sentiment, fresh Wall Street target

18 December 2025

After Hours Trading·Analyst Ratings·Bank of America·Investment Strategies·Stock Market

Arista Networks Stock (ANET) News Today: Fortinet AI Data Center Partnership, Morgan Stanley Target Cut, and Wall Street’s 2026 Forecasts

December 17, 2025 — Arista Networks, Inc. (NYSE: ANET) is back in focus for investors on Wednesday as a mix of AI-infrastructure headlines, analyst updates, and technical commentary reshapes the near-term narrative around one of the market’s most closely watched

17 December 2025

Analyst Ratings·Artificial Intelligence·Business Partnerships·Market News·Technology Stocks

Analyst Ratings News 17 December 2025 - 18 December 2025